Iress (ASX:IRE) Shares Reprice Around A Sharper Margin Story

Iress walked into this result with the stock up roughly 21% over three months and a modest 30 day gain, yet shares now sit at A$6.99 after a weak week. The mood has cooled just as the numbers highlight something different. The real headline is margins. Cash earnings before interest, tax, depreciation and amortisation jumped to a 24.5% margin in H1, while guidance points to higher full year cash EBITDA and underlying profit after tax.

Investors considering the valuation discount and trailing earnings strength now need to decide if this margin story feels durable or looks like a one day sentiment swing.

Is Iress trading at a genuine discount on a 13.8x P/E and a share price 29.3% below the provided A$9.89 DCF value, or is the slower forecast growth telling a different story? See how those numbers line up against detailed cash flow assumptions on our valuation analysis for Iress.

H1 2026 Earnings Summary

• Revenue (H1 2026 vs H1 2025): A$251.8m vs A$297.2m
• Net Income (H1 2026 vs H1 2025): A$32.0m vs A$17.3m
• Basic EPS (H1 2026 vs H1 2025): A$0.171 vs A$0.093
• Cash EBITDA Margin (H1 2026): 24.5%, compared with a lower margin in the prior year

Prefer clean charts instead of another dense page of earnings tables and ratios? See Iress' full visual breakdown, including how valuation compares with its recent margin story, in the company report for Iress.

Iress margin thesis meets early execution milestones

Bulls have argued that Iress can turn a slower topline into a higher quality, higher margin software business. The latest half-year results go some way to supporting that view. Revenue from continuing operations grew in the low single digits on a constant currency basis, while cash EBITDA margin reached 24.5% in H1. That aligns with management’s aim to build a more recurring, software-led model rather than focus on one-off project spikes.

The cost-efficiency program is also progressing ahead of prior expectations. Iress has already locked in A$31.5m of annualised savings, with a further A$6m to A$9m targeted for H2. Guidance for full-year cash EBITDA of A$121m to A$126m and an exit margin run rate of at least 25% indicates that margin expansion is being treated as a core and actionable part of the strategy rather than a longer-term aspiration.

Compare Iress' efforts to lift its cash EBITDA margin and achieve cost savings with how the street is reacting. See the consensus price target analysis for Iress to check whether analyst targets are moving in step with this margin story or signaling a disconnect.

Iress bear case on growth and costs faces a mixed test

The bearish view is that Iress is stuck with flat revenue, longer sales cycles and messy stranded costs that cap margins once the early cost cuts roll through. H1 does not fully support that, but it does not clear the deck either. Continuing revenue grew only low single digits on a constant currency basis and FY26 guidance points to just 1% to 2% revenue growth. That sits close to the more cautious revenue scenarios. Management also flagged longer UK sales cycles and a shortfall in nonrecurring project work, which fits the concern that new platforms may take time to convert into material wins.

On the other hand, the bear worry that stranded cost savings would slip is not playing out so far. Annualised efficiencies of A$31.5m are already locked in and a further A$6m to A$9m is targeted for H2.

After such aggressive cost work and a dividend that free cash flow does not fully cover, review whether Iress faces deeper structural issues in the risk analysis for Iress which shows 1 important warning sign.

Stay Ahead With Simply Wall St

If the margin story at Iress has your attention, register for free with Simply Wall St and add it to a Watchlist to track the share price against fair value and watch how the thesis progresses. After you decide to take a position, keep your focus on what matters with the Portfolio Command Center that highlights key fundamental and valuation updates instead of day to day noise. For a broader view on Iress and similar stocks, lean on the collective insight from thousands of investors through the Community. This way you can spot potential catalysts and risks early and stay a step ahead of the wider market.

Seeking Alternatives Beyond Iress?

Fresh ideas can move from quiet to breakout quickly, and the best entry points often slip away while attention is elsewhere. Scan these under the radar themes and act now.

• Spot companies with strong income potential and steady momentum by reviewing the curated 3 dividend fortresses before yields change or investors crowd into the same few stocks.
• Look for opportunities in digital assets and infrastructure through the carefully filtered 20 cryptocurrency and blockchain stocks while sentiment, volumes and valuations still sit under the radar.
• Track potential compounders supported by robust finances using the focused list of solid balance sheet and fundamentals stocks (21 results) so you can review quality stories as market attention develops.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com